Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods  Mucosal biopsies were obtained from the desc...

Full description

Saved in:
Bibliographic Details
Published in:Neurogastroenterology and motility Vol. 24; no. 12; pp. 1118 - e570
Main Authors: Balestra, B., Vicini, R., Cremon, C., Zecchi, L., Dothel, G., Vasina, V., De Giorgio, R., Paccapelo, A., Pastoris, O., Stanghellini, V., Corinaldesi, R., De Ponti, F., Tonini, M., Barbara, G.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-12-2012
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods  Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results  Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences  Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS.
AbstractList Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods  Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results  Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences  Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS.
Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods  Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results  Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences  Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS.
Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS.
Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS.
Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. [PUBLICATION ABSTRACT]
Author Zecchi, L.
Tonini, M.
Cremon, C.
Vasina, V.
Balestra, B.
Vicini, R.
Paccapelo, A.
Corinaldesi, R.
De Giorgio, R.
Pastoris, O.
De Ponti, F.
Barbara, G.
Stanghellini, V.
Dothel, G.
Author_xml – sequence: 1
  givenname: B.
  surname: Balestra
  fullname: Balestra, B.
  organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy
– sequence: 2
  givenname: R.
  surname: Vicini
  fullname: Vicini, R.
  organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy
– sequence: 3
  givenname: C.
  surname: Cremon
  fullname: Cremon, C.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 4
  givenname: L.
  surname: Zecchi
  fullname: Zecchi, L.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 5
  givenname: G.
  surname: Dothel
  fullname: Dothel, G.
  organization: Department of Pharmacology, University of Bologna, Bologna, Italy
– sequence: 6
  givenname: V.
  surname: Vasina
  fullname: Vasina, V.
  organization: Department of Pharmacology, University of Bologna, Bologna, Italy
– sequence: 7
  givenname: R.
  surname: De Giorgio
  fullname: De Giorgio, R.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 8
  givenname: A.
  surname: Paccapelo
  fullname: Paccapelo, A.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 9
  givenname: O.
  surname: Pastoris
  fullname: Pastoris, O.
  organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy
– sequence: 10
  givenname: V.
  surname: Stanghellini
  fullname: Stanghellini, V.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 11
  givenname: R.
  surname: Corinaldesi
  fullname: Corinaldesi, R.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
– sequence: 12
  givenname: F.
  surname: De Ponti
  fullname: De Ponti, F.
  organization: Department of Pharmacology, University of Bologna, Bologna, Italy
– sequence: 13
  givenname: M.
  surname: Tonini
  fullname: Tonini, M.
  organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy
– sequence: 14
  givenname: G.
  surname: Barbara
  fullname: Barbara, G.
  organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22937879$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v1DAQhi1URD_gwB9AlriUQ1p_xHFyhFVpkbbbC1UlLpbtTKhLYi-2o-3-e7xs2wMSc5mx9Mwja95jdOCDB4TeU3JGS537KZxRRgh5hY4ob0TFupYd7GZBKtoxcYiOU3ooQMPq5g06ZKzjspXdEfKLMAbvLJ5mG5Ie8QS90znEhIcYJrzW2YHPCW9cvscuRpe1GQGbsIERp63vCwUYHq3LpfkMscjsfRidh_hzJw7Fhj3MMfj0Fr0e9Jjg3VM_QbdfL74vrqrlzeW3xedlZWtWk6omoC0MRDDZEugF7yU1vDc9r40ECkIyyfnADNW2hq4hwHV5w2AMJQMwfoJO9951DL9nSFlNLlkYR-0hzElRJqSsW8ZoQT_-gz6EOfryO0VpJ2sqGtkW6tOesjGkFGFQ6-gmHbeKErULQZUQ1N8QCvvhyTibcs4X8vnqBTjfAxs3wvb_JrW6vnlWVvsNlzI8vmzo-Es1kkuh7laXqrn-8mO5uloqwf8APo-j3Q
CitedBy_id crossref_primary_10_1016_j_lfs_2014_12_017
crossref_primary_10_1038_srep25203
crossref_primary_10_1371_journal_pone_0080925
crossref_primary_10_1080_13543784_2018_1442434
crossref_primary_10_1111_nmo_14595
crossref_primary_10_1111_nmo_12928
crossref_primary_10_1016_j_jcmgh_2018_02_001
crossref_primary_10_1007_s11302_013_9397_9
crossref_primary_10_1038_ajg_2015_158
crossref_primary_10_1111_nmo_14634
crossref_primary_10_1111_nmo_12525
crossref_primary_10_1111_1751_2980_12379
crossref_primary_10_1111_apt_13283
crossref_primary_10_1097_MPG_0000000000003588
crossref_primary_10_1016_j_jphs_2023_02_001
crossref_primary_10_1152_ajpgi_00144_2015
crossref_primary_10_1111_1751_2980_12971
crossref_primary_10_1111_nmo_13192
crossref_primary_10_1111_nmo_13157
crossref_primary_10_1007_s00436_018_5792_z
crossref_primary_10_33805_2690_2613_110
crossref_primary_10_5056_jnm21132
crossref_primary_10_1136_gutjnl_2015_309151
crossref_primary_10_3748_wjg_v22_i45_9871
crossref_primary_10_5056_jnm15137
crossref_primary_10_3748_wjg_v22_i46_10198
crossref_primary_10_1111_bph_12989
crossref_primary_10_1038_ajg_2013_245
crossref_primary_10_3390_gidisord3040016
crossref_primary_10_1136_gutjnl_2015_311339
crossref_primary_10_3390_ijms24087440
crossref_primary_10_5056_jnm20175
crossref_primary_10_1097_MOG_0000000000000070
crossref_primary_10_1111_nmo_12039
crossref_primary_10_1053_j_gastro_2013_01_040
crossref_primary_10_1111_nmo_13718
crossref_primary_10_3389_fncel_2015_00452
crossref_primary_10_1007_s11011_023_01187_6
crossref_primary_10_3390_jcm10153429
crossref_primary_10_1080_15384101_2015_1093712
crossref_primary_10_1038_nrgastro_2014_127
crossref_primary_10_3389_fnins_2023_934341
crossref_primary_10_1186_s12967_023_04215_2
crossref_primary_10_3389_fmed_2023_1083351
crossref_primary_10_1038_nrgastro_2014_200
crossref_primary_10_1111_nmo_13579
crossref_primary_10_1111_nmo_12316
crossref_primary_10_3389_fnins_2015_00465
crossref_primary_10_3389_fphar_2021_596686
crossref_primary_10_15406_ghoa_2020_11_00412
crossref_primary_10_1155_2018_9252984
crossref_primary_10_3390_molecules25184314
crossref_primary_10_1136_gutjnl_2012_304066
crossref_primary_10_1155_2016_2031480
crossref_primary_10_1136_gutjnl_2014_308188
crossref_primary_10_22141_2308_2097_55_2_2021_233635
Cites_doi 10.1111/j.1365-2982.2005.00685.x
10.1016/j.tips.2007.08.003
10.1159/000268131
10.1053/j.gastro.2004.02.017
10.1136/gut.2004.048876
10.1016/0014-2999(96)00037-4
10.1136/gut.2006.100594
10.1113/jphysiol.1982.sp014407
10.1113/jphysiol.1968.sp008392
10.1182/blood.V97.3.587
10.1152/physrev.00043.2006
10.1136/gut.2008.169250
10.1111/j.1476-5381.2009.00287.x
10.1007/BF01303164
10.1016/j.ejphar.2004.07.020
10.1097/00042737-200410000-00010
10.7326/0003-4819-111-8-671
10.1007/s00210-005-0021-6
10.1038/ajg.2008.94
10.1053/j.gastro.2005.11.061
10.1056/NEJMcp0801447
10.1136/gut.45.2008.ii43
10.1111/j.1365-2982.2008.01100.x
10.1111/j.1365-2036.2011.04684.x
10.1111/j.1365-2982.2004.00591.x
10.1111/j.1572-0241.2002.05475.x
10.1136/gut.2007.138982
10.2174/138161209788186335
10.1002/cne.10801
10.1113/jphysiol.2004.060848
10.1172/JCI29255
10.1136/gut.2010.213108
10.1053/j.gastro.2009.07.005
10.1136/gut.29.3.342
10.1053/j.gastro.2003.11.055
10.1038/sj.bjp.0705768
10.1053/j.gastro.2009.02.074
10.1038/ajg.2011.423
10.1111/j.1365-2982.2008.01259.x
10.1136/gut.51.suppl_1.i41
10.1523/JNEUROSCI.22-12-04767.2002
10.1016/j.jneuroim.2007.09.013
10.1111/j.1365-2036.2009.04041.x
10.1053/j.gastro.2006.11.039
10.1016/S1471-4892(02)00215-1
ContentType Journal Article
Copyright 2012 Blackwell Publishing Ltd
2012 Blackwell Publishing Ltd.
Copyright_xml – notice: 2012 Blackwell Publishing Ltd
– notice: 2012 Blackwell Publishing Ltd.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
K9.
DOI 10.1111/nmo.12000
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
DatabaseTitleList CrossRef

Neurosciences Abstracts
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1365-2982
EndPage e570
ExternalDocumentID 2824341781
10_1111_nmo_12000
22937879
NMO12000
ark_67375_WNG_6MBZLNHL_5
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29N
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7TK
K9.
ID FETCH-LOGICAL-c4240-40eacef052780ed53d71b3dbd34b7e1e572733f2b1ac4e960e3a33fefbb10fe23
IEDL.DBID 33P
ISSN 1350-1925
IngestDate Thu Aug 15 23:50:18 EDT 2024
Tue Nov 19 06:34:28 EST 2024
Thu Nov 21 22:27:42 EST 2024
Tue Aug 27 13:46:44 EDT 2024
Sat Aug 24 01:09:08 EDT 2024
Wed Oct 30 09:55:48 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2012 Blackwell Publishing Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4240-40eacef052780ed53d71b3dbd34b7e1e572733f2b1ac4e960e3a33fefbb10fe23
Notes ark:/67375/WNG-6MBZLNHL-5
ArticleID:NMO12000
istex:B646DBF6669CA79FF45A260E37FA109B0A2874DD
These authors equally contributed to the manuscript.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 22937879
PQID 1197415678
PQPubID 1006536
PageCount 10
ParticipantIDs proquest_miscellaneous_1257748221
proquest_journals_1197415678
crossref_primary_10_1111_nmo_12000
pubmed_primary_22937879
wiley_primary_10_1111_nmo_12000_NMO12000
istex_primary_ark_67375_WNG_6MBZLNHL_5
PublicationCentury 2000
PublicationDate 2012-12
December 2012
2012-Dec
2012-12-00
20121201
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle Neurogastroenterology and motility
PublicationTitleAlternate Neurogastroenterol Motil
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut 2009; 58: 1300-11.
Bartho L, Holzer P, Lembeck F, Szolcsanyi J. Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to release of substance P. J Physiol 1982; 332: 157-67.
Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil 2006; 18: 6-17.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
Liu YJ, Jackson DM, Blackham A. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations. Eur J Pharmacol 1996; 303: 187-92.
Corinaldesi R, Stanghellini V, Cremon C et al. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther 2009; 30: 245-52.
Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
Monro RL, Bertrand PP, Bornstein JC. ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum. J Physiol 2004; 556: 571-84.
Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
Dekkers JA, Akkermans LM, Kroese AB. Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum. Am J Physiol 1997; 272: G1451-6.
Dunlop SP, Jenkins D, Spiller RC. Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol 2004; 16: 1011-5.
Wareham K, Vial C, Wykes RC, Bradding P, Seward EP. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol 2009; 157: 1215-24.
Ward SM, Bayguinov J, Won KJ, Grundy D, Berthoud HR. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 2003; 465: 121-35.
Bassotti G, Villanacci V, Nascimbeni R et al. Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther 2011; 34: 92-9.
Wood JD. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 2004; 127: 635-57.
Mayer EA. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008; 358: 1692-9.
Chang L, Adeyemo M, Karagiannides I et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012; 107: 262-72.
Geber C, Mang CF, Kilbinger H. Facilitation and inhibition by capsaicin of cholinergic neurotransmission in the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol 2006; 372: 277-83.
Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37.
Suzuki R, Furuno T, Okamoto K, Teshima R, Nakanishi M. ATP plays a role in neurite stimulation with activated mast cells. J Neuroimmunol 2007; 192: 49-56.
Buhner S, Li Q, Vignali S et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-34.
Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-96.
Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797.
Vergnolle N. Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 2005; 54: 867-74.
Klooker TK, Braak B, Koopman KE et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213-21.
Paton WD, Zar MA. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 1968; 194: 13-33.
Sharif NA, Crider JY, Xu SX, Williams GW. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. J Pharmacol Exp Ther 2000; 293: 321-8.
Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
Steck N, Mueller K, Schemann M, Haller D. Bacterial proteases in IBD and IBS. Gut 2011; doi: 10.1136/gutjnl-2011-300775.
Cenac N, Andrews CN, Holzhausen M et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117: 636-47.
Bartho L, Benko R, Patacchini R et al. Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Pharmacol 2004; 500: 143-57.
Burnstock G. Purinergic receptors and pain. Curr Pharm Des 2009; 15: 1717-35.
Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5.
Rao SS, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut 1988; 29: 342-5.
Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004; 141: 1313-20.
Rong W, Keating C, Sun B, Dong L, Grundy D. Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease. Neurogastroenterol Motil 2009; 21: 665-71.
Buhner S, Li Q, Berger T et al. Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients. Neurogastroenterol Motil 2010; 22: 1.
Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 2008; 20: 900-7.
De Giorgio R, Barbara G, Furness JB, Tonini M. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol Sci 2007; 28: 473-81.
Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005; 17: 281-9.
Guilarte M, Santos J, de Torres I et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-9.
Frieling T, Rupprecht C, Kroese AB, Schemann M. Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon. Am J Physiol 1994; 266: G132-9.
Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-9.
Cremon C, Gargano L, Morselli-Labate AM et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400.
Barbara G, Stanghellini V, Cremon C et al. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. Dig Dis 2009; 27(Suppl. 1): 115-21.
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II43-7.
Sharkey KA, Mawe GM. Neuroimmune and epithelial interactions in intestinal inflammation. Curr Opin Pharmacol 2002; 2: 669-77.
Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51(Suppl. 1): i41-4.
Bertrand PP, Bornstein JC. ATP as a putative sensory mediator: activation of intrinsic sensory neurons of the myenteric plexus via P2X receptors. J Neurosci 2002; 22: 4767-75.
2004; 127
2004; 126
2010; 59
2002; 97
1997; 272
2002; 51
1989; 111
2006; 130
2006; 372
1999; 45
2000; 293
2009; 157
1996; 303
1994; 266
2007; 28
2010; 22
2009; 58
1993; 38
2007; 132
1982; 332
2008; 358
2008; 20
2009; 15
2001; 97
2004; 500
2009; 21
2011
2004; 141
2002; 2
2006; 18
2008; 57
2011; 34
1968; 194
2007; 56
2009; 136
2012; 107
2009; 27
2009; 137
2004; 556
2009; 30
2007; 117
1988; 29
2007; 192
2004; 16
2002; 22
2005; 54
2007; 87
2005; 17
2003; 465
2009; 104
e_1_2_10_23_2
e_1_2_10_21_2
e_1_2_10_40_2
Dekkers JA (e_1_2_10_41_2) 1997; 272
e_1_2_10_2_2
e_1_2_10_18_2
e_1_2_10_39_2
e_1_2_10_4_2
e_1_2_10_16_2
e_1_2_10_37_2
e_1_2_10_6_2
e_1_2_10_14_2
e_1_2_10_35_2
e_1_2_10_11_2
e_1_2_10_34_2
e_1_2_10_8_2
e_1_2_10_32_2
e_1_2_10_30_2
e_1_2_10_51_2
e_1_2_10_29_2
e_1_2_10_27_2
e_1_2_10_48_2
e_1_2_10_25_2
e_1_2_10_46_2
e_1_2_10_22_2
e_1_2_10_45_2
Sharif NA (e_1_2_10_20_2) 2000; 293
e_1_2_10_43_2
e_1_2_10_19_2
e_1_2_10_3_2
e_1_2_10_17_2
e_1_2_10_5_2
e_1_2_10_15_2
e_1_2_10_38_2
Steck N (e_1_2_10_24_2) 2011
e_1_2_10_7_2
e_1_2_10_13_2
e_1_2_10_36_2
e_1_2_10_9_2
e_1_2_10_12_2
e_1_2_10_33_2
e_1_2_10_10_2
e_1_2_10_31_2
e_1_2_10_50_2
Frieling T (e_1_2_10_42_2) 1994; 266
Buhner S (e_1_2_10_44_2) 2010; 22
e_1_2_10_28_2
e_1_2_10_26_2
e_1_2_10_49_2
e_1_2_10_47_2
References_xml – volume: 157
  start-page: 1215
  year: 2009
  end-page: 24
  article-title: Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells
  publication-title: Br J Pharmacol
– volume: 27
  start-page: 115
  issue: Suppl. 1
  year: 2009
  end-page: 21
  article-title: Aminosalicylates and other anti‐inflammatory compounds for irritable bowel syndrome
  publication-title: Dig Dis
– volume: 58
  start-page: 1300
  year: 2009
  end-page: 11
  article-title: Neuroimmune mechanisms in postoperative ileus
  publication-title: Gut
– volume: 126
  start-page: 693
  year: 2004
  end-page: 702
  article-title: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
  publication-title: Gastroenterology
– volume: 372
  start-page: 277
  year: 2006
  end-page: 83
  article-title: Facilitation and inhibition by capsaicin of cholinergic neurotransmission in the guinea‐pig small intestine
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
– volume: 266
  start-page: G132
  year: 1994
  end-page: 9
  article-title: Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon
  publication-title: Am J Physiol
– volume: 104
  start-page: 392
  year: 2009
  end-page: 400
  article-title: Mucosal immune activation in irritable bowel syndrome: gender‐dependence and association with digestive symptoms
  publication-title: Am J Gastroenterol
– volume: 20
  start-page: 900
  year: 2008
  end-page: 7
  article-title: Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients
  publication-title: Neurogastroenterol Motil
– volume: 16
  start-page: 1011
  year: 2004
  end-page: 5
  article-title: Age‐related decline in rectal mucosal lymphocytes and mast cells
  publication-title: Eur J Gastroenterol Hepatol
– volume: 500
  start-page: 143
  year: 2004
  end-page: 57
  article-title: Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification
  publication-title: Eur J Pharmacol
– volume: 29
  start-page: 342
  year: 1988
  end-page: 5
  article-title: Symptoms and stool patterns in patients with ulcerative colitis
  publication-title: Gut
– volume: 130
  start-page: 1480
  year: 2006
  end-page: 91
  article-title: Functional bowel disorders
  publication-title: Gastroenterology
– volume: 57
  start-page: 923
  year: 2008
  end-page: 9
  article-title: Increased capsaicin receptor TRPV1‐expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
  publication-title: Gut
– volume: 136
  start-page: 1979
  year: 2009
  end-page: 88
  article-title: Postinfectious irritable bowel syndrome
  publication-title: Gastroenterology
– volume: 56
  start-page: 203
  year: 2007
  end-page: 9
  article-title: Diarrhoea‐predominant IBS patients show mast cell activation and hyperplasia in the jejunum
  publication-title: Gut
– volume: 54
  start-page: 867
  year: 2005
  end-page: 74
  article-title: Clinical relevance of proteinase activated receptors (pars) in the gut
  publication-title: Gut
– volume: 303
  start-page: 187
  year: 1996
  end-page: 92
  article-title: Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations
  publication-title: Eur J Pharmacol
– volume: 132
  start-page: 26
  year: 2007
  end-page: 37
  article-title: Mast cell‐dependent excitation of visceral‐nociceptive sensory neurons in irritable bowel syndrome
  publication-title: Gastroenterology
– volume: 28
  start-page: 473
  year: 2007
  end-page: 81
  article-title: Novel therapeutic targets for enteric nervous system disorders
  publication-title: Trends Pharmacol Sci
– volume: 97
  start-page: 389
  year: 2002
  end-page: 96
  article-title: Quality of life in inflammatory bowel disease in remission: the impact of IBS‐like symptoms and associated psychological factors
  publication-title: Am J Gastroenterol
– volume: 293
  start-page: 321
  year: 2000
  end-page: 8
  article-title: Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids
  publication-title: J Pharmacol Exp Ther
– volume: 117
  start-page: 636
  year: 2007
  end-page: 47
  article-title: Role for protease activity in visceral pain in irritable bowel syndrome
  publication-title: J Clin Invest
– volume: 556
  start-page: 571
  year: 2004
  end-page: 84
  article-title: ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum
  publication-title: J Physiol
– volume: 137
  start-page: 1425
  year: 2009
  end-page: 34
  article-title: Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome
  publication-title: Gastroenterology
– volume: 59
  start-page: 1213
  year: 2010
  end-page: 21
  article-title: The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
  publication-title: Gut
– volume: 465
  start-page: 121
  year: 2003
  end-page: 35
  article-title: Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract
  publication-title: J Comp Neurol
– volume: 97
  start-page: 587
  year: 2001
  end-page: 600
  article-title: Nucleotide receptors: an emerging family of regulatory molecules in blood cells
  publication-title: Blood
– volume: 141
  start-page: 1313
  year: 2004
  end-page: 20
  article-title: Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function
  publication-title: Br J Pharmacol
– volume: 358
  start-page: 1692
  year: 2008
  end-page: 9
  article-title: Clinical practice. Irritable bowel syndrome
  publication-title: N Engl J Med
– volume: 2
  start-page: 669
  year: 2002
  end-page: 77
  article-title: Neuroimmune and epithelial interactions in intestinal inflammation
  publication-title: Curr Opin Pharmacol
– volume: 127
  start-page: 635
  year: 2004
  end-page: 57
  article-title: Enteric neuroimmunophysiology and pathophysiology
  publication-title: Gastroenterology
– volume: 21
  start-page: 665
  year: 2009
  end-page: 71
  article-title: Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease
  publication-title: Neurogastroenterol Motil
– volume: 194
  start-page: 13
  year: 1968
  end-page: 33
  article-title: The origin of acetylcholine released from guinea‐pig intestine and longitudinal muscle strips
  publication-title: J Physiol
– volume: 15
  start-page: 1717
  year: 2009
  end-page: 35
  article-title: Purinergic receptors and pain
  publication-title: Curr Pharm Des
– volume: 87
  start-page: 659
  year: 2007
  end-page: 797
  article-title: Physiology and pathophysiology of purinergic neurotransmission
  publication-title: Physiol Rev
– volume: 332
  start-page: 157
  year: 1982
  end-page: 67
  article-title: Evidence that the contractile response of the guinea‐pig ileum to capsaicin is due to release of substance P
  publication-title: J Physiol
– volume: 107
  start-page: 262
  year: 2012
  end-page: 72
  article-title: Serum and colonic mucosal immune markers in irritable bowel syndrome
  publication-title: Am J Gastroenterol
– volume: 51
  start-page: i41
  issue: Suppl. 1
  year: 2002
  end-page: 4
  article-title: A role for inflammation in irritable bowel syndrome?
  publication-title: Gut
– volume: 192
  start-page: 49
  year: 2007
  end-page: 56
  article-title: ATP plays a role in neurite stimulation with activated mast cells
  publication-title: J Neuroimmunol
– volume: 38
  start-page: 1590
  year: 1993
  end-page: 5
  article-title: Terminal ileal mucosal mast cells in irritable bowel syndrome
  publication-title: Dig Dis Sci
– volume: 272
  start-page: G1451
  year: 1997
  end-page: 6
  article-title: Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum
  publication-title: Am J Physiol
– volume: 111
  start-page: 671
  year: 1989
  end-page: 4
  article-title: A patient questionnaire to identify bowel disease
  publication-title: Ann Intern Med
– volume: 22
  start-page: 4767
  year: 2002
  end-page: 75
  article-title: ATP as a putative sensory mediator: activation of intrinsic sensory neurons of the myenteric plexus via P2X receptors
  publication-title: J Neurosci
– volume: 30
  start-page: 245
  year: 2009
  end-page: 52
  article-title: Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study
  publication-title: Aliment Pharmacol Ther
– volume: 18
  start-page: 6
  year: 2006
  end-page: 17
  article-title: Functional gastrointestinal disorders and mast cells: implications for therapy
  publication-title: Neurogastroenterol Motil
– volume: 17
  start-page: 281
  year: 2005
  end-page: 9
  article-title: Human mast cell mediator cocktail excites neurons in human and guinea‐pig enteric nervous system
  publication-title: Neurogastroenterol Motil
– year: 2011
  article-title: Bacterial proteases in IBD and IBS
  publication-title: Gut
– volume: 34
  start-page: 92
  year: 2011
  end-page: 9
  article-title: Colonic mast cells in controls and slow transit constipation patients
  publication-title: Aliment Pharmacol Ther
– volume: 22
  start-page: 1
  year: 2010
  article-title: Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients
  publication-title: Neurogastroenterol Motil
– volume: 45
  start-page: II43
  issue: Suppl. 2
  year: 1999
  end-page: 7
  article-title: Functional bowel disorders and functional abdominal pain
  publication-title: Gut
– ident: e_1_2_10_9_2
  doi: 10.1111/j.1365-2982.2005.00685.x
– ident: e_1_2_10_47_2
  doi: 10.1016/j.tips.2007.08.003
– ident: e_1_2_10_49_2
  doi: 10.1159/000268131
– ident: e_1_2_10_40_2
  doi: 10.1053/j.gastro.2004.02.017
– ident: e_1_2_10_23_2
  doi: 10.1136/gut.2004.048876
– ident: e_1_2_10_21_2
  doi: 10.1016/0014-2999(96)00037-4
– volume: 272
  start-page: G1451
  year: 1997
  ident: e_1_2_10_41_2
  article-title: Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum
  publication-title: Am J Physiol
  contributor:
    fullname: Dekkers JA
– ident: e_1_2_10_8_2
  doi: 10.1136/gut.2006.100594
– ident: e_1_2_10_39_2
  doi: 10.1113/jphysiol.1982.sp014407
– ident: e_1_2_10_19_2
  doi: 10.1113/jphysiol.1968.sp008392
– ident: e_1_2_10_27_2
  doi: 10.1182/blood.V97.3.587
– ident: e_1_2_10_25_2
  doi: 10.1152/physrev.00043.2006
– ident: e_1_2_10_16_2
  doi: 10.1136/gut.2008.169250
– ident: e_1_2_10_28_2
  doi: 10.1111/j.1476-5381.2009.00287.x
– ident: e_1_2_10_7_2
  doi: 10.1007/BF01303164
– ident: e_1_2_10_37_2
  doi: 10.1016/j.ejphar.2004.07.020
– ident: e_1_2_10_51_2
  doi: 10.1097/00042737-200410000-00010
– ident: e_1_2_10_18_2
  doi: 10.7326/0003-4819-111-8-671
– year: 2011
  ident: e_1_2_10_24_2
  article-title: Bacterial proteases in IBD and IBS
  publication-title: Gut
  contributor:
    fullname: Steck N
– ident: e_1_2_10_38_2
  doi: 10.1007/s00210-005-0021-6
– ident: e_1_2_10_45_2
  doi: 10.1038/ajg.2008.94
– ident: e_1_2_10_2_2
  doi: 10.1053/j.gastro.2005.11.061
– ident: e_1_2_10_48_2
  doi: 10.1056/NEJMcp0801447
– ident: e_1_2_10_17_2
  doi: 10.1136/gut.45.2008.ii43
– ident: e_1_2_10_43_2
  doi: 10.1111/j.1365-2982.2008.01100.x
– ident: e_1_2_10_15_2
  doi: 10.1111/j.1365-2036.2011.04684.x
– ident: e_1_2_10_22_2
  doi: 10.1111/j.1365-2982.2004.00591.x
– ident: e_1_2_10_4_2
  doi: 10.1111/j.1572-0241.2002.05475.x
– ident: e_1_2_10_35_2
  doi: 10.1136/gut.2007.138982
– ident: e_1_2_10_30_2
  doi: 10.2174/138161209788186335
– ident: e_1_2_10_36_2
  doi: 10.1002/cne.10801
– ident: e_1_2_10_32_2
  doi: 10.1113/jphysiol.2004.060848
– ident: e_1_2_10_10_2
  doi: 10.1172/JCI29255
– ident: e_1_2_10_13_2
  doi: 10.1136/gut.2010.213108
– ident: e_1_2_10_12_2
  doi: 10.1053/j.gastro.2009.07.005
– ident: e_1_2_10_46_2
  doi: 10.1136/gut.29.3.342
– ident: e_1_2_10_6_2
  doi: 10.1053/j.gastro.2003.11.055
– ident: e_1_2_10_34_2
  doi: 10.1038/sj.bjp.0705768
– volume: 22
  start-page: 1
  year: 2010
  ident: e_1_2_10_44_2
  article-title: Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients
  publication-title: Neurogastroenterol Motil
  contributor:
    fullname: Buhner S
– ident: e_1_2_10_5_2
  doi: 10.1053/j.gastro.2009.02.074
– ident: e_1_2_10_14_2
  doi: 10.1038/ajg.2011.423
– ident: e_1_2_10_31_2
  doi: 10.1111/j.1365-2982.2008.01259.x
– ident: e_1_2_10_3_2
  doi: 10.1136/gut.51.suppl_1.i41
– volume: 293
  start-page: 321
  year: 2000
  ident: e_1_2_10_20_2
  article-title: Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Sharif NA
– ident: e_1_2_10_33_2
  doi: 10.1523/JNEUROSCI.22-12-04767.2002
– ident: e_1_2_10_26_2
  doi: 10.1016/j.jneuroim.2007.09.013
– ident: e_1_2_10_50_2
  doi: 10.1111/j.1365-2036.2009.04041.x
– ident: e_1_2_10_11_2
  doi: 10.1053/j.gastro.2006.11.039
– volume: 266
  start-page: G132
  year: 1994
  ident: e_1_2_10_42_2
  article-title: Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon
  publication-title: Am J Physiol
  contributor:
    fullname: Frieling T
– ident: e_1_2_10_29_2
  doi: 10.1016/S1471-4892(02)00215-1
SSID ssj0006246
Score 2.322789
Snippet Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with...
Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel...
Background  Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with...
Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1118
SubjectTerms Adult
Animals
Antagonists
Biopsy
Capsaicin receptors
capsazepine
Cell activation
Cells
Cholinergic Neurons - metabolism
Colon
Colon - immunology
Colon - metabolism
Colon - pathology
Culture Media, Conditioned - pharmacology
Enteric nervous system
Female
Guinea Pigs
Humans
Hypersensitivity
Inflammation
inflammatory mucosal mediators
Intestinal Mucosa - immunology
Intestinal Mucosa - metabolism
Intestinal Mucosa - pathology
Irritable bowel syndrome
Irritable Bowel Syndrome - immunology
Irritable Bowel Syndrome - metabolism
Irritable Bowel Syndrome - pathology
Male
Mast cells
Mast Cells - immunology
Mast Cells - metabolism
Mast Cells - pathology
Motor neurons
Motor Neurons - metabolism
Mucosa
Muscles
myenteric plexus
Myenteric Plexus - metabolism
Neurons
prostaglandin D2
prostaglandin receptors
Purine P2X receptors
Rodents
Serine proteinase
twitch contractions
Title Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons
URI https://api.istex.fr/ark:/67375/WNG-6MBZLNHL-5/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.12000
https://www.ncbi.nlm.nih.gov/pubmed/22937879
https://www.proquest.com/docview/1197415678
https://search.proquest.com/docview/1257748221
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BkBAvG9tgZF8yCE28BCV20qTiaRsbfVgLEiAQL1YcX6SJ1ZmaVdv--905H9okkJB4S1PXtXy-8-_Odz8DvB0nJq-S3IbSjFTI9CehiVIZWhkVpTSG9mwODUy-ZrOf-ccTpsn50NfCtPwQQ8CNNcPba1bwwjT3lNzN6_cxF5qQ_SUvwZdvqC-DFR7JtrJIpVFIKCbtWIU4i2f45YO96AlP682fgOZD3Oo3ntO1_xryc1jt8KY4bBfIOjxCtwGbh4587fmtOBA-A9SH1jfg6bQ7aN8Ed0zv3Hkp5pzRTh34ChO-mUdwQYro6FgbwXFccb7gEIO5QGHqa7wQPQ2CwJuSIK1g3k-yt4JNrS825I5r6k14Ok3XvIDvpyffjidhdzVDWCaEAcjrJIONFUk1yyO0qbJZbJQ1ViUmwxhThkWqkiYuygTJS0JV0GesjImjCqV6CSuudvgKBJY246OgShIWwqg0aW5NmctxElsZV-MA3vRC0pctA4fuPReaUO0nNIADL76hRbH4zSlrWap_zD7p0fTo19lscqbTAHZ7-epOWxvNR6nsyGZ5AK-Hr0nP-PCkcFgvqQ3ZtiwhOBUHsNWui-HPJGEmMnw01Hde_H8fp55NP_uH7X9vugPPCKXJNodmF1auFkvcg8eNXe77JX8HUzcDLA
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED6xTQJeGGzAwgYYhCZeghI7aVJpL2NsFNEGJIZAvFhxfJGmrQ5qqRj__e6cH2ISSEi8panrWj7f-bvz3WeAF-PE5HWS21CakQqZ_iQ0USpDK6OyksbQns2hgcmnrPiavzlmmpyDvham5YcYAm6sGd5es4JzQPo3LXfz5lXMlSZrsJGMaCFyAYf6ONjhkWxri1QahYRj0o5XiPN4hp9e2402eGIv_wQ1ryNXv_WcbP7foO_CnQ5yisN2jdyDG-i2YPvQkbs9_yX2hU8C9dH1Lbg5687at8Ed0Tt3Vok5J7VTB77IhC_nEVyTIjpG1qXgUK44W3CUwVygMM1PvBA9E4LAy4pQrWDqTzK5gq2trzfkjhvqTXhGTbe8D59Pjk-PJmF3O0NYJQQDyPEkm401CTbLI7SpsllslDVWJSbDGFNGRqqWJi6rBMlRQlXSZ6yNiaMapXoA665xuAMCK5vxaVAtCQ5hVJk0t6bK5TiJrYzrcQDPeynp7y0Jh-6dF5pQ7Sc0gH0vv6FFuTjnrLUs1V-Kt3o0e_1tWkymOg1grxew7hR2qfk0lX3ZLA_g2fA1qRqfn5QOmxW1IfOWJYSo4gAetgtj-DNJsIlsHw31pZf_38epi9kH__Do35s-hVuT09lUT98V73fhNoE22abU7MH6j8UKH8Pa0q6e-PV_BaWjB1Q
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xTZp4YbDxkTHAIDTxEpTYSZOKp7GtFNGGSYBAvFhxfJEmVmdqqRj_PXfOh5gEEhJvaeq6ls93_t357meA5-PE5HWS21CakQqZ_iQ0USpDK6OyksbQns2hgemHrPiSn5wyTc6rvham5YcYAm6sGd5es4Jf2vo3JXeL5mXMhSYbsJUQDGfifKXOBjM8km1pkUqjkGBM2tEKcRrP8NNrm9EWz-vVn5DmdeDqd57Jzn-N-Tbc6gCnOGpXyB24gW4X9o4cOduLn-JQ-BRQH1vfhe15d9K-B-6Y3rnzSiw4pZ068CUmfDWP4IoU0fGxrgQHcsX5kmMM5gKFaX7gheh5EAReVYRpBRN_ksEVbGt9tSF33FBvwvNputVd-DQ5_Xg8Dbu7GcIqIRBAbidZbKxJrFkeoU2VzWKjrLEqMRnGmDIuUrU0cVklSG4SqpI-Y21MHNUo1T3YdI3DByCwshmfBdWSwBBGlUlza6pcjpPYyrgeB_CsF5K-bCk4dO-60IRqP6EBHHrxDS3K5TfOWctS_bl4o0fz119nxXSm0wAOevnqTl1Xms9S2ZPN8gCeDl-TovHpSemwWVMbMm5ZQngqDuB-uy6GP5MEmsjy0VBfePH_fZy6mL_3D_v_3vQJbJ-dTPTsbfHuIdwkxCbbfJoD2Py-XOMj2FjZ9WO_-n8BcIoF-g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Colonic+mucosal+mediators+from+patients+with+irritable+bowel+syndrome+excite+enteric+cholinergic+motor+neurons&rft.jtitle=Neurogastroenterology+and+motility&rft.au=Balestra%2C+B.&rft.au=Vicini%2C+R.&rft.au=Cremon%2C+C.&rft.au=Zecchi%2C+L.&rft.date=2012-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1350-1925&rft.eissn=1365-2982&rft.volume=24&rft.issue=12&rft.spage=1118&rft.epage=e570&rft_id=info:doi/10.1111%2Fnmo.12000&rft.externalDBID=10.1111%252Fnmo.12000&rft.externalDocID=NMO12000
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-1925&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-1925&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-1925&client=summon